Fundraising FoxBraeburn Pharmaceuticals
Princeton, US · Delaware corporation · 2 known investors
Find your way into Braeburn Pharmaceuticals
Sign up to see every warm intro you have to Braeburn Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Braeburn Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DJ
David J. McIntyreChief Financial Officer and Treasurer
MD
Michael DerkaczChief Executive Officer and President
AM
Asher M. RubinSecretary
Board
AK
Argeris Karabelas, Ph.D.Board director
SL
Seth L. Harrison, M.D.Chairman
DH
Dennis H. Langer, J. D., M.D.Board director
JB
Jeffrey BerkowitzBoard director
BM
Brian MarkisonBoard director
PK
Patrick KennedyBoard director
Investors · 2
New Leaf Venture PartnersreportedNew York
How we know: funding news · Not right? Tell us
RA CapitalreportedBoston
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$110M disclosed across 1 round · 2018
▶$110MraisedJan 2018 · 8 investors · BiotechnologyRule 506(b)
▶$110MraisedJan 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dennis H. Langer, J. D., M.D.Director
- Jeffrey BerkowitzDirector
- David J. McIntyreExecutive Officer
- Asher M. RubinExecutive Officer
- Brian MarkisonDirector
- Argeris Karabelas, Ph.D.Director
- Patrick KennedyDirector
- Michael DerkaczExecutive Officer, Director
- Seth L. Harrison, M.D.Executive Officer, Director
- Offering amount
- $110M
- Amount sold
- $110M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Braeburn Pharmaceuticals's investors?
- Braeburn Pharmaceuticals's investors include New Leaf Venture Partners, RA Capital.
- How much funding has Braeburn Pharmaceuticals raised?
- Braeburn Pharmaceuticals has disclosed $110M raised across 1 round.
- Where is Braeburn Pharmaceuticals headquartered?
- Braeburn Pharmaceuticals is headquartered in Princeton, US.